Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis
This study has been completed.
Study NCT00004794 Information provided by Office of Rare Diseases (ORD)
First Received: February 24, 2000 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cytomegalovirus Retinitis
Acquired Immunodeficiency Syndrome
Additional conditions recognized in this trial
Cytomegalovirus Infections
HIV Infections
Immunologic Deficiency Syndromes
Retinitis
Syndrome
More general conditions related to this trial
Disease
DNA Virus Infections
Eye Diseases
Eye Infections
Eye Infections, Viral
Herpesviridae Infections
Immune System Diseases
Lentivirus Infections
Pathologic Processes
Retinal Diseases
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
cidofovir
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antineoplastic Agents
Antiviral Agents
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
National Center for Research Resources (NCRR)
Northwestern University
Back to top of Main Content
